Widely experienced multi-national pharmaceutical executive in multiple countries, with a bent in later life to life science start-ups. Current & previous Board roles include: Chairman of CuroNZ, Genesis R&D, Phytomedics, Phylogica, Dentman AG and Bionik World; Director of Wool Equities, Corra Life Sciences, Encoate, Cortech, Source MDx. and Biomatters, plus involvement in 18 other biotech/hi-tech startups including PhotoNZ, Cytran and Sepracor; partner, Inventages life science VC fund. Previous roles include: President, Europe for Bristol-Myers Squibb; Schering AG (now Bayer Pharma) in the UK, NZ, Sweden, USA and Germany; Founding CEO of Proacta and CoDa Therapeutics
